Maverick Citizen

What’s next after shortened TB treatment fails in key trial?

By Elri Voigt

Maverick Citizen

New drug-resistant TB medicines will save lives but high costs remain a concern for health equity

By Daniel Steyn and Nathan Geffen

Maverick Citizen

South Africa to receive donation of new child-friendly drug-resistant TB medicines

By Marcus Low

Maverick Citizen

Experts call for better screening and treatment of TB during pregnancy

By Tiyese Jeranji for Spotlight

South Africa

Women in Health: Francesca Conradie – from HIV to groundbreaking TB research

By Aisha Abdool Karim

South Africa

Shorter, simpler drug-resistant TB treatment expected in SA later in 2022

By Catherine Tomlinson

South Africa

Free State pushing to get TB patients back into care after hundreds drop out of treatment

By Refilwe Mochoari

South Africa

Minimising nasty side effects: Important TB drug is effective at lower dose, study finds

By Tiyese Jeranji and Marcus Low for Spotlight

South Africa

Support for TB patients just a phone call away

By Tiyese Jeranji for Spotlight

South Africa

Hundreds in SA with highly drug-resistant TB to get new three-drug regimen

By Tiyese Jeranji for Spotlight

South Africa

Covid-19: Lockdown takes heavy toll on SA’s TB response

By Kathryn Cleary for Spotlight